Enhabit, Inc. reported positive fourth quarter results driven by strong growth in home health Medicare Advantage admissions, continued payor innovation success, and improved quality outcomes. Despite a slight decrease in total net service revenue, the company saw significant increases in non-episodic admissions and improved hospice cost efficiency.
Net service revenue for Q4 2023 was $260.6 million, a slight decrease from $263.2 million in Q4 2022.
Adjusted EBITDA for Q4 2023 was $25.2 million, down from $30.3 million in Q4 2022.
Home health non-episodic admissions grew by 34.2% year over year, contributing to a total admission growth of 3.9%.
Hospice cost per day decreased to $76, stabilizing after three quarters at $77.
Enhabit is providing full-year 2024 guidance with projected net service revenue between $1,076 million and $1,102 million, Adjusted EBITDA between $98 million and $110 million, and Adjusted EPS between $0.12 and $0.43.
Visualization of income flow from segment revenue to net income